Certified by Founder Lodge
Cambridge Innovation Capital
United Kingdom - Cambridge
INVESTOR
1 Disclosed Funding Rounds $11,500,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for
| Company | Date | Round | Raised |
|---|---|---|---|
 Salience Labs |
May, 12 ,2022 | Seed | $11,500,000 |
 Seldon |
March, 17 ,2023 | Series B | $20,000,000 |
 Mosaic TX |
April, 05 ,2023 | Series A | $28,000,000 |
 Complement Therapeutics |
April, 18 ,2023 | Series A | $78,929,000 |
 Riverlane |
April, 24 ,2023 | Series B | $18,685,000 |
 T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Secondmind |
November, 29 ,2023 | Unknown | $16,000,000 |
 Nuclera |
October, 17 ,2024 | Unknown | $75,000,000 |
 Cambridge GaN Devices Ltd |
February, 19 ,2025 | Series C | $32,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
